WO2005014655A3 - Conjugates of hydroxyalkyl starch and a protein - Google Patents
Conjugates of hydroxyalkyl starch and a protein Download PDFInfo
- Publication number
- WO2005014655A3 WO2005014655A3 PCT/EP2004/008821 EP2004008821W WO2005014655A3 WO 2005014655 A3 WO2005014655 A3 WO 2005014655A3 EP 2004008821 W EP2004008821 W EP 2004008821W WO 2005014655 A3 WO2005014655 A3 WO 2005014655A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- conjugates
- protein
- hydroxyalkyl starch
- relates
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007502303A JP4937105B2 (en) | 2004-03-11 | 2005-03-11 | Conjugates of hydroxyalkyl starch and protein |
CA002558725A CA2558725A1 (en) | 2004-03-11 | 2005-03-11 | Conjugates of hydroxyalkyl starch and a protein |
EP10011838A EP2270036A3 (en) | 2004-03-11 | 2005-03-11 | Hasylated polypeptides |
TW094107518A TW200600518A (en) | 2004-03-11 | 2005-03-11 | Conjugates of hydroxyalkyl starch and a protein |
ARP050100959A AR048006A1 (en) | 2004-03-11 | 2005-03-11 | CONJUGATES OF ALMIDON DE HIDROXIALQUILO AND A PROTEIN |
AU2005226844A AU2005226844B2 (en) | 2004-03-11 | 2005-03-11 | Conjugates of hydroxyalkyl starch and a protein |
KR1020067020677A KR101303620B1 (en) | 2004-03-11 | 2005-03-11 | Conjugates of hydroxyalkyl starch and a protein |
EP10011839A EP2270037A3 (en) | 2004-03-11 | 2005-03-11 | Hasylated Factor IX |
EA200601670A EA014103B1 (en) | 2004-03-11 | 2005-03-11 | Conjugate comprising protein and polymer or derivative thereof (variants), method of producing conjugate and pharmaceutical composition comprising thereof |
ES05715994.9T ES2438216T3 (en) | 2004-03-11 | 2005-03-11 | Conjugates of hydroxyalkylamidone and a protein |
CN2005800078077A CN1933857B (en) | 2004-03-11 | 2005-03-11 | Conjugates of hydroxyalkyl starch and a protein |
PCT/EP2005/002637 WO2005092390A2 (en) | 2004-03-11 | 2005-03-11 | Conjugates of hydroxyalkyl starch and a protein |
BRPI0508628-0A BRPI0508628A (en) | 2004-03-11 | 2005-03-11 | hydroxyalkyl starch conjugates and a protein |
EP05715994.9A EP1799267B1 (en) | 2004-03-11 | 2005-03-11 | Conjugates of hydroxyalkyl starch and a protein |
US11/518,558 US8017739B2 (en) | 2004-03-11 | 2006-09-08 | Conjugates of hydroxyalkyl starch and a protein |
US13/018,648 US8840879B2 (en) | 2004-03-11 | 2011-02-01 | Conjugates of hydroxyalkyl starch and a protein |
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2003/008859 WO2004024777A1 (en) | 2002-09-11 | 2003-08-08 | Hydroxyalkyl starch derivatives |
EPPCT/EP03/08859 | 2003-08-08 | ||
EPPCT/EP03/08858 | 2003-08-08 | ||
PCT/EP2003/008829 WO2004024776A1 (en) | 2002-09-11 | 2003-08-08 | Method of producing hydroxyalkyl starch derivatives |
EPPCT/EP03/08829 | 2003-08-08 | ||
PCT/EP2003/008858 WO2004024761A1 (en) | 2002-09-11 | 2003-08-08 | Hasylated polypeptides, especially hasylated erythropoietin |
US55217404P | 2004-03-11 | 2004-03-11 | |
EP04005849.7 | 2004-03-11 | ||
EP04005849 | 2004-03-11 | ||
US60/552,174 | 2004-03-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005014655A2 WO2005014655A2 (en) | 2005-02-17 |
WO2005014655A3 true WO2005014655A3 (en) | 2005-06-16 |
Family
ID=34924480
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/008821 WO2005014655A2 (en) | 2003-08-08 | 2004-08-06 | Conjugates of hydroxyalkyl starch and a protein |
PCT/EP2005/002637 WO2005092390A2 (en) | 2004-03-11 | 2005-03-11 | Conjugates of hydroxyalkyl starch and a protein |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/002637 WO2005092390A2 (en) | 2004-03-11 | 2005-03-11 | Conjugates of hydroxyalkyl starch and a protein |
Country Status (13)
Country | Link |
---|---|
US (2) | US8017739B2 (en) |
EP (3) | EP2270037A3 (en) |
JP (1) | JP4937105B2 (en) |
KR (1) | KR101303620B1 (en) |
CN (1) | CN1933857B (en) |
AR (2) | AR045450A1 (en) |
AU (1) | AU2005226844B2 (en) |
BR (1) | BRPI0508628A (en) |
CA (1) | CA2558725A1 (en) |
EA (1) | EA014103B1 (en) |
ES (1) | ES2438216T3 (en) |
TW (1) | TW200600518A (en) |
WO (2) | WO2005014655A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8840879B2 (en) | 2004-03-11 | 2014-09-23 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
US8916518B2 (en) | 2002-03-06 | 2014-12-23 | Fresenius Kabi Deutschland Gmbh | Coupling proteins to a modified polysaccharide |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10209822A1 (en) * | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Coupling of low molecular weight substances to a modified polysaccharide |
WO2004024776A1 (en) * | 2002-09-11 | 2004-03-25 | Fresenius Kabi Deutschland Gmbh | Method of producing hydroxyalkyl starch derivatives |
DE10256558A1 (en) * | 2002-12-04 | 2004-09-16 | Supramol Parenteral Colloids Gmbh | Esters of polysaccharide aldonic acids, process for their preparation and use for coupling to active pharmaceutical ingredients |
US20080274948A1 (en) * | 2003-08-08 | 2008-11-06 | Fresenius Kabi Deutschland Gmbh | Conjugates of Hydroxyalkyl Starch and G-Csf |
CN102302787A (en) * | 2004-03-11 | 2012-01-04 | 费森尤斯卡比德国有限公司 | Conjugates of hydroxyalkyl starch and a protein |
TWI417303B (en) | 2004-03-11 | 2013-12-01 | Fresenius Kabi De Gmbh | Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
AU2006222187A1 (en) * | 2005-03-11 | 2006-09-14 | Fresenius Kabi Deutschland Gmbh | Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch |
EP1762250A1 (en) * | 2005-09-12 | 2007-03-14 | Fresenius Kabi Deutschland GmbH | Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine |
WO2008013735A2 (en) * | 2006-07-21 | 2008-01-31 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-d-manno-octulsonic acid |
MX2009013682A (en) * | 2007-06-26 | 2010-08-31 | Baxter Int | Hydrolysable polymeric fmoc-linker. |
NZ583276A (en) | 2007-08-27 | 2012-06-29 | Biogenerix Ag | Liquid formulations of granulocyte colony stimulating factor and polymer conjugates |
AU2008340355B2 (en) * | 2007-12-04 | 2015-01-22 | Tekmira Pharmaceuticals Corporation | Targeting lipids |
EP2070950A1 (en) * | 2007-12-14 | 2009-06-17 | Fresenius Kabi Deutschland GmbH | Hydroxyalkyl starch derivatives and process for their preparation |
EP2070951A1 (en) | 2007-12-14 | 2009-06-17 | Fresenius Kabi Deutschland GmbH | Method for producing a hydroxyalkyl starch derivatives with two linkers |
EP2247723A1 (en) * | 2007-12-27 | 2010-11-10 | Baxter International Inc. | Chemically modified factor ix |
CA2722425A1 (en) * | 2008-04-28 | 2009-11-05 | Surmodics, Inc. | Poly-.alpha.(1-4)glucopyranose-based matrices with hydrazide crosslinking |
CN102083469A (en) * | 2008-05-06 | 2011-06-01 | 奥克塔法马股份有限公司 | Complex comprising both heparin binding proteins and heparin-hydroxyalkyl starch conjugates |
GB0811743D0 (en) | 2008-06-26 | 2008-07-30 | Hemosol Biopharma Inc | Composition |
EP2166085A1 (en) | 2008-07-16 | 2010-03-24 | Suomen Punainen Risti Veripalvelu | Divalent modified cells |
NZ623810A (en) * | 2009-07-27 | 2015-10-30 | Lipoxen Technologies Ltd | Glycopolysialylation of non-blood coagulation proteins |
US8642737B2 (en) | 2010-07-26 | 2014-02-04 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
AU2010277438B2 (en) | 2009-07-27 | 2015-08-20 | Baxalta GmbH | Glycopolysialylation of non-blood coagulation proteins |
GB2495036B (en) | 2010-07-07 | 2019-03-27 | Thermo Fisher Scient Gmbh | Kits for analyte mass spectrometry quantitation using a universal reporter |
WO2012004008A1 (en) * | 2010-07-09 | 2012-01-12 | Fresenius Kabi Deutschland Gmbh | Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
LT2598172T (en) * | 2010-07-30 | 2019-08-26 | Baxalta GmbH | Nucleophilic catalysts for oxime linkage |
NZ612320A (en) | 2010-12-22 | 2015-06-26 | Baxter Healthcare Sa | Materials and methods for conjugating a water soluble fatty acid derivative to a protein |
US20140221282A1 (en) | 2011-05-25 | 2014-08-07 | Astrazeneca Pharmaceuticals Lp | Long duration dual hormone conjugates |
JP2014520094A (en) * | 2011-05-27 | 2014-08-21 | バクスター・インターナショナル・インコーポレイテッド | Therapeutic proteins with increased half-life and methods for preparing the same |
AU2012280474A1 (en) | 2011-07-01 | 2014-01-16 | Bayer Intellectual Property Gmbh | Relaxin fusion polypeptides and uses thereof |
GB201208370D0 (en) | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Antibodies |
US9353165B2 (en) * | 2012-07-25 | 2016-05-31 | Grifols, S.A. | Purification of cell culture derived alpha1 protease inhibitor |
CZ2012842A3 (en) | 2012-11-27 | 2014-08-20 | Contipro Biotech S.R.O. | C6-C18-acylated hyaluronate-based nanomicellar composition, process for preparing C6-C18-acylated hyaluronate, process for preparing nanomicellar composition and stabilized nanomicellar composition as well as use thereof |
GB201315487D0 (en) | 2013-08-30 | 2013-10-16 | Ucb Pharma Sa | Antibodies |
EP3050893B1 (en) | 2013-09-24 | 2020-02-26 | Ajinomoto Co., Inc. | Glycoamino acid and use thereof |
GB201320066D0 (en) | 2013-11-13 | 2013-12-25 | Ucb Pharma Sa | Biological products |
CZ305153B6 (en) * | 2014-03-11 | 2015-05-20 | Contipro Biotech S.R.O. | Conjugates of hyaluronic acid oligomer or a salt thereof, process for their preparation and use |
CZ2014451A3 (en) | 2014-06-30 | 2016-01-13 | Contipro Pharma A.S. | Antitumor composition based on hyaluronic acid and inorganic nanoparticles, process of its preparation and use |
AU2015334455B2 (en) * | 2014-10-21 | 2020-05-21 | Gennova Biopharmaceuticals Limited | A novel purification process for isolation and commercial production of recombinant TNK-tPA (Tenecteplase) |
CZ309295B6 (en) | 2015-03-09 | 2022-08-10 | Contipro A.S. | Self-supporting, biodegradable film based on hydrophobized hyaluronic acid, method of its preparation and use |
GB201508180D0 (en) | 2015-05-13 | 2015-06-24 | Ucb Biopharma Sprl | Antibodies |
CZ2015398A3 (en) | 2015-06-15 | 2017-02-08 | Contipro A.S. | A method of crosslinking polysaccharides by using photolabile protecting groups |
CZ306662B6 (en) | 2015-06-26 | 2017-04-26 | Contipro A.S. | Sulphated polysaccharides derivatives, the method of their preparation, the method of their modification and the use |
GB201522394D0 (en) | 2015-12-18 | 2016-02-03 | Ucb Biopharma Sprl | Antibodies |
GB201610198D0 (en) | 2016-06-10 | 2016-07-27 | Ucb Biopharma Sprl | Anti-ige antibodies |
CZ308106B6 (en) | 2016-06-27 | 2020-01-08 | Contipro A.S. | Unsaturated derivatives of polysaccharides, preparing and using them |
JP6852397B2 (en) * | 2016-12-28 | 2021-03-31 | 株式会社島津製作所 | Preparation method and analysis method of analytical sample |
KR20210078517A (en) | 2018-10-16 | 2021-06-28 | 유씨비 바이오파마 에스알엘 | How to treat myasthenia gravis |
KR102107339B1 (en) | 2019-09-05 | 2020-05-07 | 주식회사 건바이오 | Anti-adhesion agent with inproved biocompatibility, tissue adhesion, biodegradability, anti-adhesion effect and spray apparatus having the same |
GB202001447D0 (en) | 2020-02-03 | 2020-03-18 | Ucb Biopharma Sprl | Antibodies |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994029370A1 (en) * | 1993-06-08 | 1994-12-22 | Enzon, Inc. | Factor ix - polymeric conjugates |
WO2002080979A2 (en) * | 2001-03-16 | 2002-10-17 | Fresenius Kabi Deutschland Gmbh | Conjugate of hydroxyalkyl starch and an active agent |
WO2003074087A1 (en) * | 2002-03-06 | 2003-09-12 | Biotechnologie - Gesellschaft Mittelhessen Mbh | Coupling proteins to a modified polysaccharide |
EP1398328A1 (en) * | 2002-09-11 | 2004-03-17 | Fresenius Kabi Deutschland GmbH | Hydroxyalkyl starch derivatives |
EP1424086A1 (en) * | 2002-11-26 | 2004-06-02 | Ethicon, Inc. | Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents |
Family Cites Families (199)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3191291A (en) * | 1959-01-21 | 1965-06-29 | Continental Can Co | Art of producing very thin steel and like sheets in wide strips |
CH385787A (en) * | 1960-10-04 | 1964-09-15 | Hoechst Ag | Process for the production of wetfast dyeings on cellulose textile materials |
GB1385403A (en) | 1971-07-14 | 1975-02-26 | Unilever Ltd | Process for preparing oxidised carbohydrates |
GB1419080A (en) | 1972-12-29 | 1975-12-24 | Cheminova As | Chemical compounds having juvenile hormone activity |
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4125492A (en) * | 1974-05-31 | 1978-11-14 | Pedro Cuatrecasas | Affinity chromatography of vibrio cholerae enterotoxin-ganglioside polysaccharide and the biological effects of ganglioside-containing soluble polymers |
US4061736A (en) * | 1975-02-02 | 1977-12-06 | Alza Corporation | Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin |
US4001401A (en) * | 1975-02-02 | 1977-01-04 | Alza Corporation | Blood substitute and blood plasma expander comprising polyhemoglobin |
US4001200A (en) | 1975-02-27 | 1977-01-04 | Alza Corporation | Novel polymerized, cross-linked, stromal-free hemoglobin |
US4053590A (en) * | 1975-02-27 | 1977-10-11 | Alza Corporation | Compositions of matter comprising macromolecular hemoglobin |
US4068321A (en) | 1975-09-24 | 1978-01-17 | Robert Laliberte | Adjustable pants |
CA1055932A (en) * | 1975-10-22 | 1979-06-05 | Hematech Inc. | Blood substitute based on hemoglobin |
DE2616086C2 (en) | 1976-04-13 | 1986-04-03 | Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg | Substance for use in a colloidal blood volume substitute made from hydroxyethyl starch and hemoglobin |
GB1578348A (en) * | 1976-08-17 | 1980-11-05 | Pharmacia Ab | Products and a method for the therapeutic suppression of reaginic antibodies responsible for common allergic |
FR2378094A2 (en) | 1977-01-24 | 1978-08-18 | Inst Nat Sante Rech Med | Biological reagent for diagnosis of specific illnesses - having an oxidised gluco-protein antibody on an insoluble support |
EP0019403B1 (en) | 1979-05-10 | 1985-07-31 | American Hospital Supply Corporation | Hydroxyalkyl-starch drug carrier |
DE3029307A1 (en) * | 1980-08-01 | 1982-03-04 | Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg | Blood substitute with oxygen transport properties - produced by coupling of a polysaccharide e.g. dextran with cell-free haemoglobin |
US4454161A (en) * | 1981-02-07 | 1984-06-12 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Process for the production of branching enzyme, and a method for improving the qualities of food products therewith |
JPS57206622A (en) * | 1981-06-10 | 1982-12-18 | Ajinomoto Co Inc | Blood substitute |
FI82266C (en) | 1982-10-19 | 1991-02-11 | Cetus Corp | Process for Preparation of IL-2 Mutein |
IE58011B1 (en) | 1983-05-27 | 1993-06-16 | Texas A & M Univ Sys | Method for producing a recombinant baculovirus expression vector |
IN163192B (en) | 1983-10-11 | 1988-08-20 | Fidia Spa | |
US4703008A (en) * | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
NZ210501A (en) | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
US4952496A (en) * | 1984-03-30 | 1990-08-28 | Associated Universities, Inc. | Cloning and expression of the gene for bacteriophage T7 RNA polymerase |
IL77081A (en) | 1984-12-04 | 1999-10-28 | Genetics Inst | Dna sequence encoding human erythropoietin process for the preparation thereof and a pharmaceutical composition of human erythropoietin |
DE3501616A1 (en) | 1985-01-17 | 1986-07-17 | Schering AG, 1000 Berlin und 4709 Bergkamen | Process for the preparation of hydroxylamine derivatives |
US4667016A (en) * | 1985-06-20 | 1987-05-19 | Kirin-Amgen, Inc. | Erythropoietin purification |
US4766106A (en) * | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
US5217998A (en) * | 1985-07-02 | 1993-06-08 | Biomedical Frontiers, Inc. | Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid |
US4863964A (en) * | 1985-07-02 | 1989-09-05 | Biomedical Frontiers, Inc. | Method for the stabilization of deferoxamine to chelate free ions in physiological fluid |
GB8529546D0 (en) * | 1985-11-30 | 1986-01-08 | Beecham Group Plc | Compounds |
GB8610551D0 (en) | 1986-04-30 | 1986-06-04 | Hoffmann La Roche | Polypeptide & protein derivatives |
IT1203814B (en) | 1986-06-30 | 1989-02-23 | Fidia Farmaceutici | ESTERS OF ALGINIC ACID |
FR2600894B1 (en) * | 1986-07-02 | 1989-01-13 | Centre Nat Rech Scient | MACROMOLECULAR CONJUGATES OF HEMOGLOBIN, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS |
US5362853A (en) * | 1986-12-23 | 1994-11-08 | Kyowa Hakko Kogyo Co., Ltd. | Polypeptide derivatives of human granulocyte colony stimulating factor |
US5214132A (en) * | 1986-12-23 | 1993-05-25 | Kyowa Hakko Kogyo Co., Ltd. | Polypeptide derivatives of human granulocyte colony stimulating factor |
US4836964A (en) | 1987-07-02 | 1989-06-06 | Tsai Son Kung | Method of producing a bow holding handle |
JP2594123B2 (en) * | 1987-09-12 | 1997-03-26 | 株式会社林原生物化学研究所 | Desensitizer |
EP0307827A3 (en) | 1987-09-15 | 1989-12-27 | Kuraray Co., Ltd. | Novel macromolecular complexes, process for producing same and medicinal use of such complexes |
IL84252A (en) | 1987-10-23 | 1994-02-27 | Yissum Res Dev Co | Phospholipase inhibiting compositions |
US4904584A (en) * | 1987-12-23 | 1990-02-27 | Genetics Institute, Inc. | Site-specific homogeneous modification of polypeptides |
US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
DK110188D0 (en) | 1988-03-02 | 1988-03-02 | Claus Selch Larsen | HIGH MOLECULAR WEIGHT PRODRUG DERIVATIVES OF ANTI-FLAMMATORY DRUGS |
US4994278A (en) | 1988-03-04 | 1991-02-19 | Noven Pharmaceuticals, Inc. | Breathable backing |
US5541297A (en) | 1988-04-01 | 1996-07-30 | Immunomedics, Inc. | Therapeutic conjugates of toxins and drugs |
FR2630329B1 (en) | 1988-04-20 | 1991-07-05 | Merieux Inst | MACROMOLECULAR CONJUGATES OF HEMOGLOBIN, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS |
IT1219942B (en) | 1988-05-13 | 1990-05-24 | Fidia Farmaceutici | POLYSACCHARIDIC ESTERS |
US4900780A (en) * | 1988-05-25 | 1990-02-13 | Masonic Medical Research Laboratory | Acellular resuscitative fluid |
US4925677A (en) * | 1988-08-31 | 1990-05-15 | Theratech, Inc. | Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
US5420105A (en) * | 1988-09-23 | 1995-05-30 | Gustavson; Linda M. | Polymeric carriers for non-covalent drug conjugation |
US5218092A (en) * | 1988-09-29 | 1993-06-08 | Kyowa Hakko Kogyo Co., Ltd. | Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains |
DE3836600A1 (en) | 1988-10-27 | 1990-05-03 | Wolff Walsrode Ag | CARBONIC ESTERES OF POLYSACCHARIDES AND METHOD FOR THE PRODUCTION THEREOF |
DE68925966T2 (en) * | 1988-12-22 | 1996-08-29 | Kirin Amgen Inc | CHEMICALLY MODIFIED GRANULOCYTE COLONY EXCITING FACTOR |
US5166322A (en) | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
US6261800B1 (en) * | 1989-05-05 | 2001-07-17 | Genentech, Inc. | Luteinizing hormone/choriogonadotropin (LH/CG) receptor |
WO1990015628A1 (en) | 1989-06-14 | 1990-12-27 | Cetus Corporation | Polymer/antibiotic conjugate |
DE19975071I2 (en) | 1989-06-16 | 2000-02-03 | Fresenius Ag | Hydroxyethyl starch as a plasma expander Process for their production and use as a colloidal plasma substitute |
JP2896580B2 (en) | 1989-08-25 | 1999-05-31 | チッソ株式会社 | Amylose-lysozyme hybrid, activated sugar and its production |
JP2838800B2 (en) * | 1989-09-02 | 1998-12-16 | 株式会社林原生物化学研究所 | Desensitizer |
WO1991005867A1 (en) | 1989-10-13 | 1991-05-02 | Amgen Inc. | Erythropoietin isoforms |
JP2975632B2 (en) | 1990-03-30 | 1999-11-10 | 生化学工業株式会社 | Glycosaminoglycan-modified protein |
US5169784A (en) | 1990-09-17 | 1992-12-08 | The Texas A & M University System | Baculovirus dual promoter expression vector |
DE563249T1 (en) | 1990-12-19 | 1994-03-03 | Advanced Magnetics Inc | TARGETING THERAPEUTIC AGENTS BY USING POLYSACCHARIDES. |
DK130991D0 (en) * | 1991-07-04 | 1991-07-04 | Immunodex K S | POLYMER CONJUGATES |
US5281698A (en) * | 1991-07-23 | 1994-01-25 | Cetus Oncology Corporation | Preparation of an activated polymer ester for protein conjugation |
DE4130807A1 (en) | 1991-09-17 | 1993-03-18 | Wolff Walsrode Ag | METHOD FOR PRODUCING POLYSACCHARIDE CARBONATES |
AU4406793A (en) | 1992-06-04 | 1993-12-30 | Clover Consolidated, Limited | Water-soluble polymeric carriers for drug delivery |
EP0648239A4 (en) | 1992-07-02 | 1995-09-27 | Collagen Corp | Biocompatible polymer conjugates. |
US6172208B1 (en) * | 1992-07-06 | 2001-01-09 | Genzyme Corporation | Oligonucleotides modified with conjugate groups |
AU5098193A (en) | 1992-09-01 | 1994-03-29 | Berlex Laboratories, Inc. | Glycolation of glycosylated macromolecules |
GB2270920B (en) | 1992-09-25 | 1997-04-02 | Univ Keele | Alginate-bioactive agent conjugates |
JPH08504210A (en) | 1992-12-07 | 1996-05-07 | マガイニン ファーマシューティカルズ,インク. | Treatment of septic shock using conjugated bioactive peptides |
FI935485A (en) | 1992-12-09 | 1994-06-10 | Ortho Pharma Corp | The PEG-hydrazone and PEG-oxime bonds form reagents and protein derivatives thereof |
CA2110543A1 (en) | 1992-12-09 | 1994-06-10 | David E. Wright | Peg hydrazone and peg oxime linkage forming reagents and protein derivatives thereof |
NZ250375A (en) | 1992-12-09 | 1995-07-26 | Ortho Pharma Corp | Peg hydrazone and peg oxime linkage forming reagents and protein derivatives |
EP0601417A3 (en) * | 1992-12-11 | 1998-07-01 | Hoechst Aktiengesellschaft | Physiologically compatible and degradable polymer-based carbohydrate receptor blockers, a method for their preparation and their use |
US5581476A (en) * | 1993-01-28 | 1996-12-03 | Amgen Inc. | Computer-based methods and articles of manufacture for preparing G-CSF analogs |
DK0646130T3 (en) | 1993-03-16 | 1997-06-02 | Hemosol Inc | Selective crosslinking of hemoglobins by oxidized, ring-opened saccharides |
AU7097094A (en) | 1993-06-01 | 1994-12-20 | Enzon, Inc. | Carbohydrate-modified polymer conjugates with erythropoietic activity |
CN1057534C (en) | 1993-08-17 | 2000-10-18 | 柯瑞英-艾格公司 | Erythropoietin analogs |
GB9317618D0 (en) | 1993-08-24 | 1993-10-06 | Royal Free Hosp School Med | Polymer modifications |
US5840900A (en) * | 1993-10-20 | 1998-11-24 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5711944A (en) | 1993-11-10 | 1998-01-27 | Enzon, Inc. | Interferon polymer conjugates |
JPH07188291A (en) | 1993-12-27 | 1995-07-25 | Hayashibara Biochem Lab Inc | Protein, its production and use |
US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
WO1996041813A2 (en) | 1994-11-09 | 1996-12-27 | Offord Robin E | Functionalized polymers for site-specific attachment |
JPH10510831A (en) | 1994-12-22 | 1998-10-20 | アクセス ファーマシューティカルズ, インコーポレイテッド | Complex of dermatan sulfate and drug to improve drug |
US5876980A (en) * | 1995-04-11 | 1999-03-02 | Cytel Corporation | Enzymatic synthesis of oligosaccharides |
US6214331B1 (en) * | 1995-06-06 | 2001-04-10 | C. R. Bard, Inc. | Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained |
WO1996040662A2 (en) | 1995-06-07 | 1996-12-19 | Cellpro, Incorporated | Aminooxy-containing linker compounds and their application in conjugates |
US5736533A (en) * | 1995-06-07 | 1998-04-07 | Neose Technologies, Inc. | Bacterial inhibition with an oligosaccharide compound |
WO1997021452A2 (en) | 1995-12-14 | 1997-06-19 | Advanced Magnetics, Inc. | Macromolecular prodrugs of nucleotide analogs |
US5723589A (en) * | 1995-12-21 | 1998-03-03 | Icn Pharmaceuticals | Carbohydrate conjugated bio-active compounds |
AU725287B2 (en) | 1996-02-15 | 2000-10-12 | Novozymes A/S | Conjugation of polypeptides |
ATE314843T1 (en) | 1996-03-12 | 2006-02-15 | Pg Txl Co Lp | WATER SOLUBLE PACLITAXEL PRODRUGS |
WO1997038727A1 (en) | 1996-04-15 | 1997-10-23 | Asahi Kasei Kogyo Kabushiki Kaisha | Medicament composite |
US5795397A (en) | 1996-05-06 | 1998-08-18 | National Starch And Chemical Investment Holding Corporation | Chemically derivatized maltodextrins |
US5696152A (en) | 1996-05-07 | 1997-12-09 | Wisconsin Alumni Research Foundation | Taxol composition for use as organ preservation and cardioplegic agents |
TW517067B (en) | 1996-05-31 | 2003-01-11 | Hoffmann La Roche | Interferon conjugates |
DE19628705A1 (en) * | 1996-07-08 | 1998-01-15 | Fresenius Ag | New oxygen transport agents, hemoglobin-hydroxyethyl starch conjugates containing them, processes for their preparation and their use as blood substitutes |
US5770645A (en) * | 1996-08-02 | 1998-06-23 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
US5851984A (en) | 1996-08-16 | 1998-12-22 | Genentech, Inc. | Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides |
DE59708838D1 (en) | 1996-08-30 | 2003-01-09 | Jens Peter Fuerste | MIRROR SELECTION AND MIRROR EVOLUTION OF NUCLEIC ACIDS |
JP4113588B2 (en) | 1996-09-30 | 2008-07-09 | ユニヴァーシティ・オヴ・アーカンサス | Methods for producing immune activity using vaccine conjugates |
DE19640791A1 (en) | 1996-10-02 | 1998-04-16 | Syntesome Ges Fuer Medizinisch | Glycoconjugates as inhibitors of viral cell adhesion |
WO1998020905A2 (en) | 1996-11-08 | 1998-05-22 | Biomedical Frontiers, Inc. | Treatment of iron overload disorders |
US6011008A (en) * | 1997-01-08 | 2000-01-04 | Yissum Research Developement Company Of The Hebrew University Of Jerusalem | Conjugates of biologically active substances |
JP2001508783A (en) | 1997-01-29 | 2001-07-03 | ポリマスク・ファーマシューティカルズ・パブリック・リミテッド・カンパニー | PEGylation method |
US5952347A (en) * | 1997-03-13 | 1999-09-14 | Merck & Co., Inc. | Quinoline leukotriene antagonists |
US6299881B1 (en) * | 1997-03-24 | 2001-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts |
JPH10287554A (en) | 1997-04-16 | 1998-10-27 | Sankyo Co Ltd | Functional liposome |
US5990237A (en) * | 1997-05-21 | 1999-11-23 | Shearwater Polymers, Inc. | Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines |
DE69833487T9 (en) | 1997-06-12 | 2007-03-01 | Innovata Plc, Ruddington | POLYMER-ACTIVE CONJUGATE FOR THE TREATMENT OF CANCER |
WO1999007719A1 (en) | 1997-08-07 | 1999-02-18 | University Of Utah | Prodrugs and conjugates of thiol- and selenol- containing compounds and methods of use thereof |
US5847110A (en) | 1997-08-15 | 1998-12-08 | Biomedical Frontiers, Inc. | Method of reducing a schiff base |
WO1999017783A1 (en) | 1997-10-03 | 1999-04-15 | Galenica Pharmaceuticals, Inc. | Imine-forming polysaccharides, preparation thereof and the use thereof as adjuvants and immunostimulants |
US6875594B2 (en) * | 1997-11-13 | 2005-04-05 | The Rockefeller University | Methods of ligating expressed proteins |
US6624142B2 (en) * | 1997-12-30 | 2003-09-23 | Enzon, Inc. | Trimethyl lock based tetrapartate prodrugs |
DE19808079A1 (en) | 1998-02-20 | 1999-08-26 | Schering Ag | New hydroxyethyl starch conjugates useful as X-ray, NMR and blood-pool diagnostic agents, e.g. for diagnosis of tumors, cardiovascular disorders and inflammation |
WO1999045163A1 (en) * | 1998-03-05 | 1999-09-10 | Asahi Glass Company Ltd. | Sputtering target, transparent conductive film, and method for producing the same |
CA2233725A1 (en) * | 1998-03-31 | 1999-09-30 | Hemosol Inc. | Hemoglobin-hydroxyethyl starch complexes |
US6153655A (en) * | 1998-04-17 | 2000-11-28 | Enzon, Inc. | Terminally-branched polymeric linkers and polymeric conjugates containing the same |
FR2781767B1 (en) | 1998-07-31 | 2000-10-13 | Valois Sa | FLUID PRODUCT DISPENSING DEVICE |
FR2783838B1 (en) | 1998-09-25 | 2000-12-01 | Roquette Freres | PROCESS FOR THE PREPARATION OF A MIXTURE OF STARCH BRANCHING ENZYMES EXTRACTED FROM ALGAE |
US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
US6261594B1 (en) * | 1998-11-25 | 2001-07-17 | The University Of Akron | Chitosan-based nitric oxide donor compositions |
EP1035137A1 (en) * | 1999-03-12 | 2000-09-13 | Pasteur Merieux Serums Et Vaccins | Method for the reductive amination of polysaccharides |
ATE245153T1 (en) * | 1999-04-26 | 2003-08-15 | Neurosearch As | HETEROARYL-DIAZACYCLOALKANES, THEIR PREPARATION AND USE |
FR2792941B1 (en) | 1999-04-30 | 2001-07-27 | Roquette Freres | SOLUBLE BRANCHED GLUCOSE POLYMERS AND PROCESS FOR OBTAINING SAME |
EP1198253A2 (en) | 1999-06-18 | 2002-04-24 | ML Laboratories Plc | Biologically active materials |
CZ299516B6 (en) | 1999-07-02 | 2008-08-20 | F. Hoffmann-La Roche Ag | Erythropoietin glycoprotein conjugate, process for its preparation and use and pharmaceutical composition containing thereof |
US7279176B1 (en) * | 1999-09-02 | 2007-10-09 | Rice University | Nitric oxide-producing hydrogel materials |
US20020065410A1 (en) * | 1999-12-02 | 2002-05-30 | Antrim Richard L. | Branched starches and branched starch hydrolyzates |
US6555660B2 (en) * | 2000-01-10 | 2003-04-29 | Maxygen Holdings Ltd. | G-CSF conjugates |
US6749865B2 (en) * | 2000-02-15 | 2004-06-15 | Genzyme Corporation | Modification of biopolymers for improved drug delivery |
DK1267937T3 (en) | 2000-03-21 | 2009-08-03 | Loibner Hans Dr | Polysaccharide polypeptide conjugate |
US6586398B1 (en) * | 2000-04-07 | 2003-07-01 | Amgen, Inc. | Chemically modified novel erythropoietin stimulating protein compositions and methods |
JP2001294601A (en) | 2000-04-11 | 2001-10-23 | Akita Prefecture | Highly branched starch and method for producing the same |
JP2002003398A (en) | 2000-04-17 | 2002-01-09 | Ltt Institute Co Ltd | Sustained-release preparation, method for preparing the same, and vaccine therefrom |
EP1280566B1 (en) | 2000-05-01 | 2009-08-19 | Eidgenossisch Technische Hochschule Zürich | Growth factor modified protein matrices for tissue engineering |
DE10023051B4 (en) | 2000-05-11 | 2004-02-19 | Roche Diagnostics Gmbh | Process for the preparation of fluorescein isothiocyanate sinistrin, its use and diagnostic preparation containing fluorescein isothiocyanate sinistrin |
US6242482B1 (en) | 2000-06-05 | 2001-06-05 | United Therapeutics Corporation | Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure |
KR100396983B1 (en) | 2000-07-29 | 2003-09-02 | 이강춘 | Highly reactive branched polymer and proteins or peptides conjugated with the polymer |
DE10041541A1 (en) | 2000-08-24 | 2002-03-14 | Michael Duchene | New nucleic acid encoding moth allergens, related polypeptides and antibodies, useful in the diagnosis and treatment of arthropod allergies |
US6417347B1 (en) * | 2000-08-24 | 2002-07-09 | Scimed Life Systems, Inc. | High yield S-nitrosylation process |
EP1318827A4 (en) | 2000-09-08 | 2005-09-14 | Gryphon Therapeutics Inc | Polymer-modified synthetic proteins |
AU9650201A (en) | 2000-10-02 | 2002-04-15 | Molecular Probes Inc | Reagents for labeling biomolecules having aldehyde or ketone moieties |
IT1319666B1 (en) | 2000-11-17 | 2003-10-23 | Pharma Biotech Ltd | ANTIBIOTICS ADDUCTS WITH NATURAL POLYESACCHARIDE POLYMERS IN FORMATS AQUEOUS SOLUTIONS. |
DE10105921A1 (en) | 2001-02-09 | 2002-08-14 | Braun Melsungen Ag | Active pharmaceutical ingredients bound to colloids |
DE10126158A1 (en) | 2001-05-30 | 2002-12-12 | Novira Chem Gmbh | Mixtures of alpha-hydroxy-omega-alkoxy- and alpha-omega-dialkoxy-polyoxyalkylene containing little or no dihydroxy-polyoxyalkylene, used for coupling and modification of proteins and other bioactive molecules |
DE10129369C1 (en) | 2001-06-21 | 2003-03-06 | Fresenius Kabi De Gmbh | Water soluble antibiotic in the form of a polysaccharide conjugate containing an aminosugar |
DE10135694A1 (en) | 2001-07-21 | 2003-02-06 | Supramol Parenteral Colloids | New amphiphilic conjugate of starch or hydroxyethylstarch, useful as drug carrier, contain e.g. fatty acyl residues, are not taken up by the reticuloendothelial system |
US6908963B2 (en) | 2001-10-09 | 2005-06-21 | Nektar Therapeutics Al, Corporation | Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith |
US7125843B2 (en) * | 2001-10-19 | 2006-10-24 | Neose Technologies, Inc. | Glycoconjugates including more than one peptide |
US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US7179617B2 (en) * | 2001-10-10 | 2007-02-20 | Neose Technologies, Inc. | Factor IX: remolding and glycoconjugation of Factor IX |
ES2556338T3 (en) | 2001-10-10 | 2016-01-15 | Novo Nordisk A/S | Remodeling and glycoconjugation of peptides |
US7629456B2 (en) | 2001-10-26 | 2009-12-08 | Noxxon Pharma Ag | Modified L-nucleic acid |
US6375846B1 (en) * | 2001-11-01 | 2002-04-23 | Harry Wellington Jarrett | Cyanogen bromide-activation of hydroxyls on silica for high pressure affinity chromatography |
DE10155098A1 (en) | 2001-11-09 | 2003-05-22 | Supramol Parenteral Colloids | Agent for protecting cell and tissue cultures against fungi, comprises water-soluble conjugate of polyene macrolide and polysaccharide |
AU2002357806A1 (en) | 2001-12-11 | 2003-06-23 | Sun Bio, Inc. | Novel monofunctional polyethylene glycol aldehydes |
US6916962B2 (en) * | 2001-12-11 | 2005-07-12 | Sun Bio, Inc. | Monofunctional polyethylene glycol aldehydes |
US20050085432A1 (en) | 2001-12-26 | 2005-04-21 | Aviva Lapidot | Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections |
DE10207072A1 (en) | 2002-02-20 | 2003-08-28 | Supramol Parenteral Colloids | New N-(haloacetylaminoalkyl) amides of starch carboxylic acids, useful as modifying agents for drugs containing thiol groups, e.g. to increase solubility or plasma half-life or reduce antigenicity |
DE10209822A1 (en) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Coupling of low molecular weight substances to a modified polysaccharide |
WO2003076490A1 (en) | 2002-03-13 | 2003-09-18 | Beijing Jiankai Technology Co., Ltd. | Hydrophilic polymer derivate with y type branch and preparation method of it medical composite comprising above compound |
DE10217994A1 (en) | 2002-04-23 | 2003-11-06 | Supramol Parenteral Colloids | A coupling product from (sic) chemical compounds of hyperbranched polysaccharide completely catabolized in the body under control of the body enzymes useful for parenteral pharmaceutically active materials |
WO2003102018A2 (en) | 2002-06-03 | 2003-12-11 | The Institute For Systems Biology | Methods for quantitative proteome analysis of glycoproteins |
AU2003254023A1 (en) | 2002-07-19 | 2004-02-09 | The General Hospital Corporation | Oxime conjugates and methods for their formation and use |
EP1591467A1 (en) | 2002-09-09 | 2005-11-02 | Nektar Therapeutics Al, Corporation | Conjugate between a polyethylene glycol having a terminal alkanal group and a human growth hormone |
AP2005003249A0 (en) | 2002-09-09 | 2005-03-31 | Nektar Therapeutics Al Corp | Water-soluble polymer alkanals. |
DE10242076A1 (en) | 2002-09-11 | 2004-03-25 | Fresenius Kabi Deutschland Gmbh | New covalently bonded conjugates of hydroxyalkyl starch with allergens, useful as modified allergens with depot effect for use in specific immunotherapy for combating allergies, e.g. hay fever |
DE02020425T1 (en) * | 2002-09-11 | 2004-07-15 | Fresenius Kabi Deutschland Gmbh | Hasylated polypeptides, especially hasylated erythropoietin |
AU2003273413A1 (en) | 2002-10-08 | 2004-05-04 | Fresenius Kabi Deutschland Gmbh | Pharmaceutically active oligosaccharide conjugates |
DE10254745A1 (en) | 2002-11-23 | 2004-06-03 | Supramol Parenteral Colloids Gmbh | New aldonic acid imidazolides of starch compounds selectively oxidized at the reducing terminal, useful for coupling with amino functions of pharmaceutically active agents, e.g. proteins |
DE10256558A1 (en) | 2002-12-04 | 2004-09-16 | Supramol Parenteral Colloids Gmbh | Esters of polysaccharide aldonic acids, process for their preparation and use for coupling to active pharmaceutical ingredients |
DE10302520A1 (en) | 2003-01-23 | 2004-08-05 | Supramol Parenteral Colloids Gmbh | Carbonic acid diester of starch fractions and their derivatives, process for their preparation and use for coupling to active pharmaceutical ingredients |
EP1653991A2 (en) | 2003-08-08 | 2006-05-10 | Fresenius Kabi Deutschland GmbH | Conjugates of a polymer and a protein linked by an oxime linking group |
US20080274948A1 (en) * | 2003-08-08 | 2008-11-06 | Fresenius Kabi Deutschland Gmbh | Conjugates of Hydroxyalkyl Starch and G-Csf |
JP2007501812A (en) | 2003-08-08 | 2007-02-01 | ノボ ノルディスク アクティーゼルスカブ | Synthesis and application of new structurally well-defined branched polymers as binders for peptides |
WO2005014655A2 (en) | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
WO2005014050A2 (en) | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and g-csf |
WO2005072778A2 (en) | 2004-01-29 | 2005-08-11 | Biosynexus, Inc. | Use of amino-oxy functional groups in the preparation of vaccines conjugates |
CA2555467C (en) | 2004-02-09 | 2012-10-09 | Noxxon Pharma Ag | Process for the production of conjugates from polysaccharides and polynucleotides |
DE102004009783A1 (en) | 2004-02-28 | 2005-09-15 | Supramol Parenteral Colloids Gmbh | Hyperbranched starch fraction, process for its preparation and its conjugates with pharmaceutical agents |
CN102302787A (en) | 2004-03-11 | 2012-01-04 | 费森尤斯卡比德国有限公司 | Conjugates of hydroxyalkyl starch and a protein |
TWI417303B (en) * | 2004-03-11 | 2013-12-01 | Fresenius Kabi De Gmbh | Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
AR048918A1 (en) | 2004-03-11 | 2006-06-14 | Fresenius Kabi De Gmbh | CONJUGADOS DE ALMIDON DE HIDROXIETILO Y ERITROPOYETINA |
WO2005112954A1 (en) | 2004-05-14 | 2005-12-01 | William Marsh Rice University | Nitric oxide releasing compositions and associated methods |
AU2006222187A1 (en) | 2005-03-11 | 2006-09-14 | Fresenius Kabi Deutschland Gmbh | Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch |
EP1877099B1 (en) | 2005-04-06 | 2012-09-19 | Genzyme Corporation | Therapeutic conjugates comprising a lysosomal enzyme, polysialic acid and a targeting moiety |
EP1762250A1 (en) | 2005-09-12 | 2007-03-14 | Fresenius Kabi Deutschland GmbH | Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine |
CA2628055C (en) | 2005-10-31 | 2013-10-01 | Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services | Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates |
JP2009093397A (en) * | 2007-10-09 | 2009-04-30 | Panasonic Corp | Touch panel and input device using the same |
EP2070951A1 (en) | 2007-12-14 | 2009-06-17 | Fresenius Kabi Deutschland GmbH | Method for producing a hydroxyalkyl starch derivatives with two linkers |
EP2070950A1 (en) | 2007-12-14 | 2009-06-17 | Fresenius Kabi Deutschland GmbH | Hydroxyalkyl starch derivatives and process for their preparation |
WO2010042638A2 (en) | 2008-10-07 | 2010-04-15 | Young Bok Lee | Hpma - docetaxel or gemcitabine conjugates and uses therefore |
-
2004
- 2004-08-06 WO PCT/EP2004/008821 patent/WO2005014655A2/en active Application Filing
- 2004-08-09 AR ARP040102853A patent/AR045450A1/en unknown
-
2005
- 2005-03-11 WO PCT/EP2005/002637 patent/WO2005092390A2/en active Application Filing
- 2005-03-11 EP EP10011839A patent/EP2270037A3/en not_active Withdrawn
- 2005-03-11 EA EA200601670A patent/EA014103B1/en not_active IP Right Cessation
- 2005-03-11 AR ARP050100959A patent/AR048006A1/en not_active Application Discontinuation
- 2005-03-11 ES ES05715994.9T patent/ES2438216T3/en active Active
- 2005-03-11 BR BRPI0508628-0A patent/BRPI0508628A/en not_active IP Right Cessation
- 2005-03-11 TW TW094107518A patent/TW200600518A/en unknown
- 2005-03-11 JP JP2007502303A patent/JP4937105B2/en not_active Expired - Fee Related
- 2005-03-11 KR KR1020067020677A patent/KR101303620B1/en not_active IP Right Cessation
- 2005-03-11 CN CN2005800078077A patent/CN1933857B/en not_active Expired - Fee Related
- 2005-03-11 AU AU2005226844A patent/AU2005226844B2/en not_active Ceased
- 2005-03-11 CA CA002558725A patent/CA2558725A1/en not_active Abandoned
- 2005-03-11 EP EP05715994.9A patent/EP1799267B1/en not_active Not-in-force
- 2005-03-11 EP EP10011838A patent/EP2270036A3/en not_active Withdrawn
-
2006
- 2006-09-08 US US11/518,558 patent/US8017739B2/en not_active Expired - Fee Related
-
2011
- 2011-02-01 US US13/018,648 patent/US8840879B2/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994029370A1 (en) * | 1993-06-08 | 1994-12-22 | Enzon, Inc. | Factor ix - polymeric conjugates |
WO2002080979A2 (en) * | 2001-03-16 | 2002-10-17 | Fresenius Kabi Deutschland Gmbh | Conjugate of hydroxyalkyl starch and an active agent |
WO2003074087A1 (en) * | 2002-03-06 | 2003-09-12 | Biotechnologie - Gesellschaft Mittelhessen Mbh | Coupling proteins to a modified polysaccharide |
EP1398328A1 (en) * | 2002-09-11 | 2004-03-17 | Fresenius Kabi Deutschland GmbH | Hydroxyalkyl starch derivatives |
EP1398327A1 (en) * | 2002-09-11 | 2004-03-17 | Fresenius Kabi Deutschland GmbH | Method of producing hydroxyalkyl starch derivatives |
WO2004024761A1 (en) * | 2002-09-11 | 2004-03-25 | Fresenius Kabi Deutschland Gmbh | Hasylated polypeptides, especially hasylated erythropoietin |
EP1424086A1 (en) * | 2002-11-26 | 2004-06-02 | Ethicon, Inc. | Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents |
Non-Patent Citations (1)
Title |
---|
SADAMOTO, REIKO ET AL: "Control of bacteria adhesion by cell-wall engineering", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY , 126(12), 3755-3761 CODEN: JACSAT; ISSN: 0002-7863, 2004, XP008035406 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8916518B2 (en) | 2002-03-06 | 2014-12-23 | Fresenius Kabi Deutschland Gmbh | Coupling proteins to a modified polysaccharide |
US8840879B2 (en) | 2004-03-11 | 2014-09-23 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
Also Published As
Publication number | Publication date |
---|---|
WO2005014655A2 (en) | 2005-02-17 |
EP2270037A2 (en) | 2011-01-05 |
KR20060129078A (en) | 2006-12-14 |
WO2005092390A3 (en) | 2006-06-08 |
EP1799267A2 (en) | 2007-06-27 |
AR048006A1 (en) | 2006-03-15 |
TW200600518A (en) | 2006-01-01 |
EA014103B1 (en) | 2010-10-29 |
WO2005092390A9 (en) | 2006-12-28 |
US20110200555A1 (en) | 2011-08-18 |
US20090047251A1 (en) | 2009-02-19 |
EP2270037A3 (en) | 2011-12-21 |
AU2005226844A1 (en) | 2005-10-06 |
CN1933857B (en) | 2011-01-05 |
CN1933857A (en) | 2007-03-21 |
ES2438216T3 (en) | 2014-01-16 |
EP1799267B1 (en) | 2013-10-23 |
EP2270036A2 (en) | 2011-01-05 |
CA2558725A1 (en) | 2005-10-06 |
AR045450A1 (en) | 2005-10-26 |
AU2005226844B2 (en) | 2011-09-08 |
US8840879B2 (en) | 2014-09-23 |
WO2005092390A2 (en) | 2005-10-06 |
JP2007527891A (en) | 2007-10-04 |
EP2270036A3 (en) | 2012-03-28 |
US8017739B2 (en) | 2011-09-13 |
EA200601670A1 (en) | 2007-02-27 |
BRPI0508628A (en) | 2007-08-07 |
KR101303620B1 (en) | 2013-09-16 |
JP4937105B2 (en) | 2012-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005014655A3 (en) | Conjugates of hydroxyalkyl starch and a protein | |
WO2005092369A3 (en) | Conjugates of hydroxyethyl starch and erythropoietin | |
TW200600519A (en) | Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination | |
EP2502935A3 (en) | Improved antibodies having altered effector function and methods for making the same | |
MX264256B (en) | Starch process. | |
WO2001034835A3 (en) | Method for the production of biopolymers with modified properties | |
EP1550674A4 (en) | Chitosan-containing polysaccharide, process for producing the same and use thereof | |
WO2005014050A3 (en) | Conjugates of hydroxyalkyl starch and g-csf | |
WO2006050341A3 (en) | Modified streptococcal polysaccharides and uses thereof | |
AU2002232819A1 (en) | Methods for the production of multimeric proteins, and related compositions | |
IL156334A0 (en) | Methods for the production of multimeric proteins, and related compositions | |
WO2004084949A3 (en) | Generating protein pro-drugs using reversible ppg linkages | |
WO2004087735A3 (en) | Proteolytic and covalent antibodies | |
AU2003275675A1 (en) | Process for producing hexahydrofurofuranol derivative, intermediate thereof and process for producing the same | |
AU2002367287A1 (en) | SOLUBLE GLcNAC PHOSPHOTRANSFERASE | |
AU2003293122A1 (en) | Methods for synthesizing polysaccharides | |
WO2003084926A3 (en) | Polymeric acyl derivatives of indoles | |
WO2006122777A3 (en) | Use of 2,5-disubstituted thiazol-4-one derivatives in drugs | |
PL376481A1 (en) | Conjugated hydroxyalkyl starch allergen compounds | |
AU2002304028A1 (en) | Continuous process for modifying starch and its derivatives by branching enzymes | |
WO2004009642A3 (en) | Libraries of heparan sulfates derivatives | |
SG145746A1 (en) | Conjugates of hydroxyalkyl starch and g-csf | |
AU2003263575A1 (en) | Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate | |
WO2001049651A3 (en) | Aminomethyl-phenyl-cyclohexanone derivatives | |
TW200519128A (en) | Conjugates of hydroxyalkyl starch and a protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |